| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| MousePheno | abnormal trigeminal ganglion morphology | 5.38e-04 | 55 | 9 | 2 | MP:0001092 | |
| MousePheno | enlarged lung | 5.38e-04 | 55 | 9 | 2 | MP:0004882 | |
| MousePheno | abnormal phalanx morphology | 1.02e-03 | 76 | 9 | 2 | MP:0005306 | |
| Domain | Arm | 9.53e-05 | 31 | 9 | 2 | PF00514 | |
| Domain | ARM | 1.59e-04 | 40 | 9 | 2 | SM00185 | |
| Domain | ARM_REPEAT | 1.59e-04 | 40 | 9 | 2 | PS50176 | |
| Domain | Armadillo | 2.21e-04 | 47 | 9 | 2 | IPR000225 | |
| Domain | - | 4.79e-03 | 222 | 9 | 2 | 1.25.10.10 | |
| Domain | ARM-like | 7.01e-03 | 270 | 9 | 2 | IPR011989 | |
| Domain | Homeodomain-like | 1.04e-02 | 332 | 9 | 2 | IPR009057 | |
| Domain | ARM-type_fold | 1.09e-02 | 339 | 9 | 2 | IPR016024 | |
| Pubmed | 8.92e-07 | 6 | 9 | 2 | 23230271 | ||
| Pubmed | A pathogenic CtBP1 missense mutation causes altered cofactor binding and transcriptional activity. | 8.92e-07 | 6 | 9 | 2 | 31041561 | |
| Pubmed | 1.12e-04 | 1103 | 9 | 4 | 34189442 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.19e-04 | 398 | 9 | 3 | 35016035 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.15e-04 | 43 | 7 | 2 | 409 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.90e-02 | 718 | 7 | 2 | 28 | |
| Coexpression | NADLER_OBESITY_UP | 1.84e-04 | 60 | 9 | 2 | M1431 | |
| Coexpression | BURTON_ADIPOGENESIS_PEAK_AT_0HR | 2.09e-04 | 64 | 9 | 2 | M1626 | |
| Coexpression | NADLER_OBESITY_UP | 2.29e-04 | 67 | 9 | 2 | MM1007 | |
| Coexpression | BURTON_ADIPOGENESIS_PEAK_AT_0HR | 2.43e-04 | 69 | 9 | 2 | MM1024 | |
| Coexpression | GSE36891_POLYIC_TLR3_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_UP | 1.19e-03 | 153 | 9 | 2 | M8789 | |
| Coexpression | DESCARTES_FETAL_LIVER_MEGAKARYOCYTES | 1.31e-03 | 161 | 9 | 2 | M40231 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ALVEOLAR_MACROPHAGE_AGEING | 1.75e-03 | 186 | 9 | 2 | MM3762 | |
| Coexpression | P53_DN.V1_DN | 1.90e-03 | 194 | 9 | 2 | M2697 | |
| Coexpression | GSE43863_NAIVE_VS_TH1_EFF_CD4_TCELL_D6_LCMV_UP | 1.90e-03 | 194 | 9 | 2 | M9723 | |
| Coexpression | GSE43863_NAIVE_VS_LY6C_INT_CXCR5POS_CD4_EFF_TCELL_D6_LCMV_UP | 1.95e-03 | 197 | 9 | 2 | M9730 | |
| Coexpression | GSE22229_RENAL_TRANSPLANT_IMMUNOSUPP_THERAPY_VS_HEALTHY_PBMC_DN | 1.99e-03 | 199 | 9 | 2 | M7479 | |
| Coexpression | GSE11924_TH1_VS_TH2_CD4_TCELL_DN | 1.99e-03 | 199 | 9 | 2 | M3160 | |
| Coexpression | GSE35435_RESTING_VS_IL4_TREATED_MACROPHAGE_DN | 1.99e-03 | 199 | 9 | 2 | M9543 | |
| Coexpression | GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_6H_DN | 1.99e-03 | 199 | 9 | 2 | M8741 | |
| Coexpression | GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN | 1.99e-03 | 199 | 9 | 2 | M5268 | |
| Coexpression | GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_UP | 1.99e-03 | 199 | 9 | 2 | M6581 | |
| Coexpression | GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_DN | 1.99e-03 | 199 | 9 | 2 | M3486 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_12H_BMDC_DN | 2.01e-03 | 200 | 9 | 2 | M3949 | |
| Coexpression | GSE27786_NKCELL_VS_NEUTROPHIL_DN | 2.01e-03 | 200 | 9 | 2 | M4859 | |
| Coexpression | GSE4142_PLASMA_CELL_VS_GC_BCELL_UP | 2.01e-03 | 200 | 9 | 2 | M6390 | |
| Coexpression | GSE19923_E2A_KO_VS_E2A_AND_HEB_KO_DP_THYMOCYTE_UP | 2.01e-03 | 200 | 9 | 2 | M7275 | |
| Coexpression | GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN | 2.01e-03 | 200 | 9 | 2 | M6650 | |
| Coexpression | GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_UP | 2.01e-03 | 200 | 9 | 2 | M6664 | |
| Coexpression | GSE39152_BRAIN_VS_SPLEEN_CD103_NEG_MEMORY_CD8_TCELL_UP | 2.01e-03 | 200 | 9 | 2 | M9075 | |
| Coexpression | GSE27786_NKTCELL_VS_NEUTROPHIL_DN | 2.01e-03 | 200 | 9 | 2 | M4869 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_UP | 2.01e-03 | 200 | 9 | 2 | M8279 | |
| Coexpression | GSE24726_WT_VS_E2_2_KO_PDC_DN | 2.01e-03 | 200 | 9 | 2 | M8061 | |
| Coexpression | GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP | 2.01e-03 | 200 | 9 | 2 | M6029 | |
| Coexpression | GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN | 2.01e-03 | 200 | 9 | 2 | M8485 | |
| Coexpression | GSE19401_UNSTIM_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP | 2.01e-03 | 200 | 9 | 2 | M7665 | |
| Coexpression | GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_UP | 2.01e-03 | 200 | 9 | 2 | M5842 | |
| Coexpression | GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_DN | 2.01e-03 | 200 | 9 | 2 | M3429 | |
| Coexpression | GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN | 2.01e-03 | 200 | 9 | 2 | M3469 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP | 2.01e-03 | 200 | 9 | 2 | M6514 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_MEGAKARYOCYTES | 2.07e-03 | 203 | 9 | 2 | M40286 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.51e-04 | 161 | 9 | 2 | bfb79277889142133ce86492a808f3083a7547e8 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.51e-04 | 161 | 9 | 2 | d6f4b0e4e3b2a4e6232a6de3d67b210e24f8c89d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_CD24|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.26e-04 | 174 | 9 | 2 | 3e29d620b7b4ab1915ddac70ee5a50d09072292b | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-04 | 181 | 9 | 2 | ad30c01290fb98adbd0caed301a584761212c977 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-04 | 181 | 9 | 2 | 3a3268a4dff8ffcb79e09f46490e138c96f8d916 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-04 | 181 | 9 | 2 | 4e81ec1580e9acb22c32c465eb46f83d1e9e424e | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-9|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 6.07e-04 | 187 | 9 | 2 | f002ff1a7cb7577f28acff008bc2aa561ac1a4bf | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.13e-04 | 188 | 9 | 2 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | COVID-19_Moderate-Platelet|World / disease group, cell group and cell class | 6.26e-04 | 190 | 9 | 2 | 6e4f4af5ba185bb022753881a26a269a544bb59b | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.46e-04 | 193 | 9 | 2 | 2d891c00b8f0aace17d4c300b63e2341dcffa199 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-04 | 194 | 9 | 2 | b294056f9bdc243263cf36dce7b62564144b9de1 | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-04 | 194 | 9 | 2 | 93b7a9065430740ec31fce4e8c14ffccb498591d | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.53e-04 | 194 | 9 | 2 | 69362e13158033de44f90f3773db6c0f27de8cb3 | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-04 | 194 | 9 | 2 | 0d2e65b44e3f143971c2fd24c4552f042b049cfa | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.53e-04 | 194 | 9 | 2 | 9709dc95fb6982b6a0467b507845d5bc17252e3e | |
| ToppCell | (1)_Osterolineage_cells-(11)_OLC-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.59e-04 | 195 | 9 | 2 | 78978d85273e5463a7f43e4c121e647fa6aba42b | |
| ToppCell | facs-Bladder-nan-18m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.59e-04 | 195 | 9 | 2 | 3e4f9ecfaa756386d816a26313b7229ec092d4e6 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.66e-04 | 196 | 9 | 2 | f47e551ba484687ba6ce8c29a085106131364042 | |
| ToppCell | Kidney-Mesangial|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients. | 6.66e-04 | 196 | 9 | 2 | 2b2cbe7f96213b7ff50442593f31820d17a2ae94 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-04 | 197 | 9 | 2 | 036c4c9b3ae80e2dc21c24a84504d3da0541f945 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-04 | 197 | 9 | 2 | cfd4cc5fb8d7a60dd5c0d2a1a7bad7ba38c19d40 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-04 | 198 | 9 | 2 | 8f202ed4692ea2c139ff05d4805c704ee4be095c | |
| ToppCell | distal-mesenchymal-Myofibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.80e-04 | 198 | 9 | 2 | beef5075ba6dcd4d0a447bc4e57efcaf2e93c546 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-04 | 198 | 9 | 2 | d3a475be01657a03fcbb0ee0a246b1e90deacaa4 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-04 | 198 | 9 | 2 | 985022c1722ab7b67675ebe814022a439e715b5e | |
| ToppCell | droplet-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.80e-04 | 198 | 9 | 2 | 1beed34f469aad07e8f674f0b668d6e1e916403c | |
| ToppCell | distal-2-mesenchymal-Myofibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.87e-04 | 199 | 9 | 2 | b8f3cf5bcfde1066bdb49b14fdc842fe9692a6b7 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-04 | 199 | 9 | 2 | 67f78c070c56e44fba36542041bf7fa1c291807c | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-04 | 199 | 9 | 2 | 1ae244b563f85c1ee8d22698f478c842a4d9c7f5 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-BMP_responsible_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 6.93e-04 | 200 | 9 | 2 | 5fb90118d3abc28d72bc483e68317255090a04c7 | |
| Drug | AC1NDVEB | 5.59e-04 | 91 | 9 | 2 | CID004632235 | |
| Drug | Etoposide [33419-42-0]; Down 200; 6.8uM; HL60; HG-U133A | 2.16e-03 | 180 | 9 | 2 | 1626_DN | |
| Drug | Dextroamphetamine | 2.28e-03 | 185 | 9 | 2 | ctd:D003913 | |
| Drug | Lycorine hydrochloride [2188-68-3]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 2.28e-03 | 185 | 9 | 2 | 4365_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Up 200; 11uM; PC3; HT_HG-U133A | 2.30e-03 | 186 | 9 | 2 | 4271_UP | |
| Disease | blood urea nitrogen measurement | 2.80e-04 | 452 | 9 | 3 | EFO_0004741 | |
| Disease | diverticular disease | 2.21e-03 | 236 | 9 | 2 | EFO_0009959 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 5.16e-03 | 364 | 9 | 2 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | S-6-hydroxywarfarin measurement | 5.27e-03 | 368 | 9 | 2 | EFO_0803326 | |
| Disease | neutrophil count | 6.96e-03 | 1382 | 9 | 3 | EFO_0004833 | |
| Disease | corneal resistance factor | 7.82e-03 | 451 | 9 | 2 | EFO_0010067 | |
| Disease | cardiovascular disease | 8.02e-03 | 457 | 9 | 2 | EFO_0000319 | |
| Disease | lymphocyte count | 8.17e-03 | 1464 | 9 | 3 | EFO_0004587 | |
| Disease | facial morphology measurement | 8.33e-03 | 466 | 9 | 2 | EFO_0007841 | |
| Disease | body fat percentage | 9.10e-03 | 488 | 9 | 2 | EFO_0007800 | |
| Disease | Liver carcinoma | 9.79e-03 | 507 | 9 | 2 | C2239176 | |
| Disease | diastolic blood pressure, systolic blood pressure | 1.67e-02 | 670 | 9 | 2 | EFO_0006335, EFO_0006336 | |
| Disease | Abnormality of refraction | 1.68e-02 | 673 | 9 | 2 | HP_0000539 | |
| Disease | platelet component distribution width | 2.09e-02 | 755 | 9 | 2 | EFO_0007984 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ARNKNNACGIANLAS | 311 | P43235 | |
| GDNRSLIANLAAANC | 146 | P55263 | |
| ANLTTCNPANANAAA | 381 | Q5W041 | |
| AAAAAAAAAAAAQCR | 11 | Q8N3X6 | |
| GALAIANFARNDANC | 336 | P52306 | |
| AAAAAAAAANQCRNL | 76 | P31271 | |
| ASACNRLLNGASQAD | 121 | Q92618 | |
| AAATNNLCEAANAAV | 2401 | Q9Y490 | |
| NLNLNLAAAAAAAAA | 331 | Q96T25 |